| Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia H Matsuo, T Chiba, S Nagamori, A Nakayama, H Domoto, K Phetdee, ... The American Journal of Human Genetics 83 (6), 744-751, 2008 | 430 | 2008 |
| Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide … K Watashi, A Sluder, T Daito, S Matsunaga, A Ryo, S Nagamori, ... Hepatology 59 (5), 1726-1737, 2014 | 294 | 2014 |
| Role of YidC in folding of polytopic membrane proteins S Nagamori, IN Smirnova, HR Kaback The Journal of cell biology 165 (1), 53-62, 2004 | 247 | 2004 |
| Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization M Iwamoto, W Saso, R Sugiyama, K Ishii, M Ohki, S Nagamori, R Suzuki, ... Proceedings of the National Academy of Sciences 116 (17), 8487-8492, 2019 | 206 | 2019 |
| Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer K Kaira, Y Sunose, K Arakawa, T Ogawa, N Sunaga, K Shimizu, ... British journal of cancer 107 (4), 632-638, 2012 | 182 | 2012 |
| Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer H Imai, K Kaira, N Oriuchi, K Shimizu, H Tominaga, N Yanagitani, ... Anticancer research 30 (12), 4819-4828, 2010 | 153 | 2010 |
| Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer M Toyoda, K Kaira, Y Ohshima, NS Ishioka, M Shino, K Sakakura, ... British journal of cancer 110 (10), 2506-2513, 2014 | 141 | 2014 |
| Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2 P Wongthai, K Hagiwara, Y Miyoshi, P Wiriyasermkul, L Wei, R Ohgaki, ... Cancer Science 106 (3), 279-286, 2015 | 137 | 2015 |
| Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET P Wiriyasermkul, S Nagamori, H Tominaga, N Oriuchi, K Kaira, H Nakao, ... Journal of Nuclear Medicine 53 (8), 1253-1261, 2012 | 135 | 2012 |
| ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer K Shimizu, K Kaira, Y Tomizawa, N Sunaga, O Kawashima, N Oriuchi, ... British journal of cancer 110 (8), 2030-2039, 2014 | 130 | 2014 |
| Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc Y Lee, P Wiriyasermkul, C Jin, L Quan, R Ohgaki, S Okuda, T Kusakizako, ... Nature structural & molecular biology 26 (6), 510-517, 2019 | 125 | 2019 |
| Manipulating phospholipids for crystallization of a membrane transport protein L Guan, IN Smirnova, G Verner, S Nagamori, HR Kaback Proceedings of the National Academy of Sciences 103 (6), 1723-1726, 2006 | 108 | 2006 |
| Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer K Kaira, Y Sunose, Y Ohshima, NS Ishioka, K Arakawa, T Ogawa, ... BMC cancer 13, 1-12, 2013 | 102 | 2013 |
| Slc3a2 mediates branched-chain amino-acid-dependent maintenance of regulatory T cells K Ikeda, M Kinoshita, H Kayama, S Nagamori, P Kongpracha, E Umemoto, ... Cell reports 21 (7), 1824-1838, 2017 | 98 | 2017 |
| NPT1/SLC17A1 is a renal urate exporter in humans and its common gain‐of‐function variant decreases the risk of renal underexcretion gout T Chiba, H Matsuo, Y Kawamura, S Nagamori, T Nishiyama, L Wei, ... Arthritis & rheumatology 67 (1), 281-287, 2015 | 91 | 2015 |
| Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1 S Nagamori, P Wiriyasermkul, ME Guarch, H Okuyama, S Nakagomi, ... Proceedings of the National Academy of Sciences 113 (3), 775-780, 2016 | 89 | 2016 |
| Interaction of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin with SGLT1 and SGLT2: inhibition kinetics, sidedness of action, and transporter-associated … R Ohgaki, L Wei, K Yamada, T Hara, C Kuriyama, S Okuda, K Ueta, ... Journal of Pharmacology and Experimental Therapeutics 358 (1), 94-102, 2016 | 87 | 2016 |
| System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line K Yamauchi, H Sakurai, T Kimura, P Wiriyasermkul, S Nagamori, Y Kanai, ... Cancer letters 276 (1), 95-101, 2009 | 84 | 2009 |
| The Sec-independent function of Escherichia coli YidC is evolutionary-conserved and essential E van Bloois, S Nagamori, G Koningstein, RS Ullers, M Preuss, B Oudega, ... Journal of Biological Chemistry 280 (13), 12996-13003, 2005 | 83 | 2005 |
| Expression of L‐type amino acid transporter 1 (LAT 1) as a prognostic and therapeutic indicator in multiple myeloma A Isoda, K Kaira, M Iwashina, N Oriuchi, H Tominaga, S Nagamori, ... Cancer science 105 (11), 1496-1502, 2014 | 71 | 2014 |
Pattama WiriyasermkulDepartment of Agriculture, Iwate UniversityVerified email at iwate-u.ac.jp
